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Abstract. 
 
Phospholipase D (PLD) enzymes catalyze 
the hydrolysis of phosphatidylcholine and are involved 
in membrane trafficking and cytoskeletal reorganiza-
tion. The 
 
Saccharomyces cerevisiae
 
 
 
SPO14
 
 gene en-
codes a PLD that is essential for meiosis. We have ana-
lyzed the role of PLD in meiosis by examining two 
mutant proteins, one with a point mutation in a con-
 
served residue (Spo14p
 
K
 
®
 
H
 
) and one with an amino-
 
terminal deletion (Spo14p
 
D
 
N
 
), neither of which can re-
store meiosis in a 
 
spo14
 
 deletion strain. Spo14p
 
K
 
®
 
H
 
 is 
enzymatically inactive, indicating that PLD activity is 
required, whereas Spo14p
 
D
 
N
 
 retains PLD catalytic ac-
tivity in vitro, indicating that PLD activity is not suffi-
cient for meiosis. To explore other aspects of Spo14 
function, we followed the localization of the enzyme 
during meiosis. Spo14p is initially distributed through-
out the cell, becomes concentrated at the spindle pole 
bodies after the meiosis I division, and at meiosis II lo-
calizes to the new spore membrane as it surrounds the 
nuclei and then expands to encapsulate the associated 
cytoplasm during the formation of spores. The catalyti-
cally inactive protein also undergoes relocalization dur-
ing meiosis; however, in the absence of PLD activity, no 
membrane is formed. In contrast, Spo14p
 
D
 
N
 
 does not 
relocalize properly, indicating that the failure of this 
protein to complement a 
 
spo14
 
 mutant is due to its in-
ability to localize its PLD activity. Furthermore, we 
find that Spo14p movement is correlated with phospho-
rylation of the protein. These experiments indicate that 
PLD participates in regulated membrane formation 
during meiosis, and that both its catalytic activity and 
subcellular redistribution are essential for this function.
 
P
 
hospholipases
 
 play a central role in cell signaling
by generating lipid second messengers in response
to a wide variety of stimuli. Phosphatidylcholine-
specific phospholipase D (PLD)
 
1
 
 catalyzes the hydrolysis
of phosphatidylcholine (PC) to produce phosphatidic acid
(PA) and choline. PA can modulate the activity of a vari-
ety of regulatory proteins in vitro, including protein ki-
nases (Bocckino et al., 1991), lipid kinases (Moritz et al.,
1992), protein phosphatases (Zhao et al., 1993), and the
neutrophil respiratory burst NADPH oxidase (Bellavite et
al., 1988). Consequently, PA is believed to be the primary
signaling molecule generated by PLD-catalyzed hydrolysis
of PC in vivo. In addition, PA can be metabolized to form
diacylglycerol (DAG), a well-characterized activator of
protein kinase C (PKC) (Nishizuka, 1995), and 
 
lyso
 
-phos-
phatidic acid, a potent mitogen that acts on specific cell
surface receptors (Guo et al., 1996). The generation of
these signaling molecules via PLD hydrolysis of PC may
be important for sustained cellular responses (Exton,
1994). Since PC is the major phospholipid component of
all cellular membranes, the intracellular location of PLD-
generated second messengers may govern the nature of
the response elicited by different stimuli.
Recent studies have suggested that PLD activation is di-
rectly involved in membrane trafficking (Ktistakis et al.,
1996) and cytoskeletal reorganization (Cross et al., 1996).
PLD is thought to function in regulated vesicular move-
ment either by activating a downstream effector essential
for trafficking and/or by altering the local structural char-
acteristics of membranes (Liscovitch and Cantley, 1995).
In support of this latter hypothesis, Ktistakis et al. (1996)
have shown a direct requirement for the production of PA
by PLD in the in vitro formation of coated vesicles from
mammalian Golgi cisternae. In yeast, DAG appears to be
the critical lipid for secretion through the Golgi complex
(Kearns et al
 
.
 
, 1997). PLD has also been proposed to regu-
late reorganization of the actin cytoskeleton by activating
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1. 
 
Abbreviations used in this paper
 
: BODIPY-PA, 2-decanoyl-1-(
 
O
 
-[11-
{4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-
 
s
 
-indacene-3-propionyl}amino]
undecyl]-
 
sn
 
-glycero-3-phosphatidate; BODIPY-PC, 2-decanoyl-1-(
 
O
 
-[11-
{4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-
 
s
 
-indacene-3-propionyl}amino]
undecyl)-
 
sn
 
-glycero-3-phosphocholine; DAG, diacylglycerol; DAPI, 4
 
9
 
-
6
 
9
 
diaminophenylindole; GFP, green fluorescent protein; HA, hemagglutinin;
PA, phosphatidic acid; PC, phosphatidylcholine; PIP
 
2
 
, phosphatidylinosi-
tol 4,5-bisphosphate; PKC, protein kinase C; PLD, phospholipase D.
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the small GTP-binding protein, Rho (Cross et al., 1996).
However, the physiological role of PLD activation in these
processes is unclear.
Sporulation in the yeast 
 
Saccharomyces cerevisiae
 
 is a
program of cellular differentiation analogous to gameto-
genesis in vertebrates. Yeast cells induced to sporulate un-
dergo meiosis, which consists of a single round of DNA
replication followed by two successive rounds of chromo-
some segregation. The four haploid nuclei are then envel-
oped by an internal membrane followed by spore wall for-
mation. This double-layered membrane is thought to arise
from the fusion of vesicles near the meiosis II spindle pole
bodies (Byers, 1981), the yeast equivalent of vertebrate
centrosomes. Genetic and cytological analyses of secretory
mutants in sporulation suggest that the vesicles that fuse to
form the membrane are derived from the Golgi complex
(Neiman, 1998). However, little is known about what dis-
tinguishes spore membrane formation from other mem-
brane trafficking events and how the haploid nuclei and
associated cytoplasm are encapsulated within the body of
the mother cell.
The 
 
Saccharomyces cerevisiae
 
 
 
SPO14 
 
gene is essential
for meiosis; 
 
spo14
 
 mutants enter meiosis and complete
meiotic prophase, but a large number of cells are unable to
progress through both of the meiotic divisions, and none
form spores (Honigberg et al., 1992; Rose et al., 1995). We
have previously shown that 
 
SPO14
 
 encodes a PLD (Rose
et al., 1995; Ella et al., 1996; Waksman et al., 1996). Ge-
netic analysis of a mutation that renders the protein cata-
lytically inactive indicates that the essential function of
Spo14p is the hydrolysis of PC (Sung et al., 1997). In this
study we show that the NH
 
2
 
-terminal region of the protein
is required for proper localization of Spo14p to the devel-
oping membrane, which forms around the haploid meiotic
nuclei and is a substrate for phosphorylation. Further-
more, cells expressing a catalytically inactive protein fail to
form the membrane. Taken together, our results indicate
that localized PLD activity is essential for elaboration of
this new internal membrane.
 
Materials and Methods
 
Strains and Genetic Procedures
 
Genotypes of yeast strains are listed in Table I. KR52-3C (Rose et al.,
1995) and NH144 (Hollingsworth et al., 1995) have been described. Yeast
manipulations were performed and media were prepared using standard
procedures (Rose et al., 1990). Yeast transformations were carried out by
the lithium acetate procedure (Ito et al., 1983).
 
Plasmid Constructions
 
pME865 contains the 6-kb 
 
SPO14 
 
complementing sequences derived
from pKR325 (Rose et al., 1995) at the XbaI-ApaI sites of pUN105
(Elledge and Davis, 1988). Three copies of the hemagglutinin epitope
(HA; Wilson et al., 1984) were introduced after amino acid 72 in the
 
SPO14
 
 open reading frame by inserting the SphI-digested product of PCR
amplification (primers 5
 
9
 
HA: AAGCATGGCGAATTCCTGCAGCCCA-
TCT and 3
 
9
 
HA: ATGCATGCAGAGCGTAATCTGGAACGT) using
plasmid SK P/X HA
 
 
 
(Neiman et al., 1997) as template, into the SphI site of
pME865. The resulting plasmid, pME940, was sequenced to determine
orientation and verify the open reading frame. Plasmid ME910 contains
the lysine to histidine change at amino acid 1098 in Spo14p and was gener-
ated by site-directed mutagenesis of pME865 as described (Sung et al.,
1997). A three-way ligation with the 2-kb XbaI-SacI fragment from
pME940, the 4-kb SacI-ApaI fragment harboring the mutation from
pME910, and the 6-kb XbaI-ApaI fragment of pUN105 was performed to
create the HA-tagged version of this mutant protein in pME1043. The
 
spo14-
 
D
 
N
 
 allele was constructed by removing the 0.45-kb EcoRI fragment
from pKR325 to generate pME419. The PCR product described above
was inserted into the unique SphI site of pME419 to generate pME1104.
These sequences were moved into a 
 
LEU2 
 
CEN plasmid by inserting the
6.0-kb XbaI-ApaI fragment from pME1104 into the corresponding sites of
pUN105 to generate pME1131. Plasmids ME962 (
 
SPO14 LEU2
 
 2
 
m
 
),
ME957 (
 
HA-SPO14 LEU2
 
 2
 
m
 
), and ME1121 (
 
HA-spo14-
 
D
 
N LEU2
 
 2
 
m
 
)
were constructed by inserting the XbaI-XhoI fragment from pME865,
pME940, and pME1104, respectively, into the corresponding sites of
YEp351 (Hill et al., 1986).
PCR amplification was performed with SK
 
1
 
GFP (Cormack et al.,
1996; generously provided by C. DeMattie and J. Konopka, SUNY, Stony
Brook) as template to generate a fragment containing the green fluores-
cent protein (GFP) (Chalfie et al., 1994) flanked with SphI sites (primers
GFP5
 
9
 
: ACATGCATGCAAAAGGAGAAGAACTTTTCACT and GFP3
 
9
 
:
ACATGCATGCTTGTATAGTTCATCCATGCC). The resulting 700-bp
SphI fragment was inserted into the SphI site of pME865 (after amino
acid 72 in the 
 
SPO14
 
 open reading frame, identical to the position of the
HA tag), creating pME1086. Sequence analysis verified orientation and
reading frame; complementation analysis indicates that the GFP–Spo14
fusion is functional. This fusion was subcloned into the XbaI and SalI sites
of the 2
 
m
 
 plasmid YEp351 on a 6-kb XbaI-XhoI fragment, generating
pME1096 (
 
GFP–SPO14 LEU2 
 
2
 
m
 
). Plasmid ME1124 (
 
GFP–spo14-
 
D
 
N
LEU2 
 
2
 
m
 
) was constructed by inserting the GFP amplification product de-
scribed above into the SphI site of pME1121; the resulting product was se-
quenced to verify orientation and reading frame. A three-way ligation was
performed with the 2.5-kb XbaI-SacI from pME1096, the 4-kb SacI-XhoI
fragment from pME1043, and the 6-kb XbaI-SalI fragment of YEp351,
generating pME1130 (
 
GFP–spo14-K
 
[
 
H LEU2
 
 2
 
m
 
]).
 
Preparation of Particulate and Cytosol Fractions
 
15 h after transfer to sporulation medium, the time of the meiotic divisions
in this strain background, yeast cells were collected by centrifugation at
1,000
 
 
 
g
 
 for 6 min. After a wash with distilled water, the cells were resus-
pended in 20 ml of spheroplast buffer A (200 mM Tris, pH 7.5, 20 mM
DTT) and incubated for 15 min at room temperature with gentle agita-
tion. The cells were pelleted by centrifugation at 1,000
 
 
 
g
 
 for 6 min and re-
suspended in 50 ml of spheroplast buffer B (50 mM Tris, pH 7.5, 500 mM
potassium chloride, 10 mM DTT). Zymolylase 100T (United States Bio-
logical, Swampscott, MA) was added (20 
 
m
 
g/ml, final concentration), and
the cells were incubated for 30 min at 30
 
8
 
C with gentle agitation. Sphero-
plasts were centrifuged at 1,000
 
 
 
g
 
 for 6 min, washed once with spheroplast
buffer B, and suspended in 1.6 ml ice-cold lysis buffer (10 mM triethanola-
mine, pH 7.5, 300 mM sorbitol, 2 mM EDTA, 50 mM sodium fluoride,
40 mM 
 
b
 
-glycerophosphate, 1 mM DTT, 2 mM PMSF, 2 mM benzami-
dine, 0.057 U/ml aprotinin, 2.5 
 
m
 
g/ml leupeptin). The cells were incubated
for 40 min at 4
 
8
 
C with gentle agitation, and the lysate was adjusted to 1 M
sorbitol in 2 ml. Unlysed cells were removed by centrifugation (1,000
 
 
 
g
 
 for
6 min at 4
 
8
 
C). The supernatant was centrifuged at 100,000
 
 
 
g
 
 for 1 h at 4
 
8
 
C
to yield the particulate (pellet) and cytosolic (supernatant) cell fractions.
The particulate fraction was washed twice with lysis buffer and suspended
in a volume of lysis buffer equal to the volume of cytosol collected. Sam-
ple buffer was then added and the samples boiled for 5 min. Equal vol-
umes of each fraction were used for immunoblot analysis.
 
Immunoprecipitations
 
Spheroplasts, prepared as described above, were suspended in 6 ml ice-
cold immunoprecipitation (IP) lysis buffer (10 mM triethanolamine, pH
7.5, 150 mM sodium chloride, 5 mM EDTA, 5 mM EGTA, 50 mM sodium
fluoride, 40 mM 
 
b
 
-glycerophosphate, 10 mM sodium pyrophosphate, 1 mM
DTT, 2 mM PMSF, 2 mM benzamidine 0.057 U/ml aprotinin, 2.5 
 
m
 
g/ml le-
upeptin) containing 1% Nonidet P-40 (wt/vol) (BDH Laboratory Sup-
plies, Poole, England). The cells were incubated at 4
 
8
 
C for 40 min with
gentle agitation. The lysate was centrifugation at 1,000
 
 
 
g
 
 for 6 min at 4
 
8
 
C
to remove unlysed cells and large cellular debris. The supernatant was
centrifuged at 15,000
 
 
 
g
 
 for 30 min at 4
 
8
 
C to yield the Nonidet P-40–soluble
(supernatant) fraction. HA-Spo14 variants were immunoprecipitated di-
rectly from this fraction using the 12CA5 monoclonal antibody, which rec-
ognizes the HA epitope (BAbCO, Richmond, CA). 1-ml aliquots (1 mg
total protein) of the Nonidet P-40–soluble fraction were incubated for 1.5 h
at 4
 
8
 
C in tubes containing 3 
 
m
 
g of affinity-purified 12CA5. Protein A–aga- 
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rose was then added (50 
 
m
 
l of a 50% suspension equilibrated in lysis
buffer), followed by a further incubation for 1.5 h at 4
 
8
 
C.
 
 
 
Immune com-
plexes were washed three times in 1 ml IP lysis buffer (without PMSF,
benzamidine, aprotinin, and leupeptin) containing 1% Nonidet P-40 (wt/
vol), three times in 1 ml of IP lysis buffer without detergent, and once in 1
ml of TBS. Protein concentrations were determined (Bradford, 1976) by
using BSA as standard.
 
Phospholipase D Assays of
Immunoprecipitated HA-Spo14p
 
HA-Spo14 variants were immunoprecipitated from Nonidet P-40–soluble
fractions of meiotic yeast as described above. The immune complex was
then split into two equal halves. One half was suspended in 20 
 
m
 
l 1
 
 3 
 
sam-
ple buffer and boiled for 5 min, and the remaining half was washed once
with 1 ml PLD assay buffer (25 mM Hepes, pH 7.0, 150 mM sodium chlo-
ride, 5 mM EGTA, 1 mM EDTA, 40 mM
 
 
 
b
 
-glycerophosphate, and 1 mM
DTT) and suspended in 50 
 
m
 
l of 2
 
3 
 
PLD assay buffer.
The PLD reaction was initiated by addition of 50 
 
m
 
l of lipid vesicles
containing 20–200 
 
m
 
M 2-decanoyl-1-(
 
O
 
-[11-{4,4-difluoro-5,7-dimethyl-4-
bora-3a,4a-diaza-
 
s
 
-indacene-3-propionyl}amino]undecyl)-
 
sn
 
-glycero-3-phos-
phocholine (BODIPY-PC; Molecular Probes, Inc., Eugene, OR) and 10
 
m
 
M PIP
 
2
 
. Lipid vesicles were prepared by bath sonication of dry lipid
films. After incubation for 30 min at 30
 
8
 
C with occasional gentle agitation,
the reaction was terminated with the addition of 375 
 
m
 
l of chloroform/
methanol (1:2 vol/vol). Chloroform (125 
 
m
 
l) and 1 M MgCl
 
2
 
 (100 
 
m
 
l ) were
then added, and the lipid products of the lower phase were extracted and
separated by TLC as described (Rose et al., 1995). The PLD reaction
products were viewed by UV, and the bands corresponding to BODIPY-PC
and 2-decanoyl-1-(
 
O
 
-[11-{4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-
 
s
 
-in-
dacene-3-propionyl}amino]undecyl)-
 
sn
 
-glycero-3-phosphatidate (BO-
DIPY-PA) were scraped from the plates and extracted with methanol. In
all cases, BODIPY-PA was the only PLD reaction product observed. The
fluorescence of the methanol extracts was determined using a Packard flu-
orometer (Meriden, CT) at 485 nm excitation and 530 nm emission. Fluo-
rescence of BODIPY-PA was quantified as a percentage of BODIPY-PC.
This value was then converted into nanomolar BODIPY-PA per relative
protein.
 
Treatment of Immunoprecipitated Protein with Shrimp 
Alkaline Phosphatase
 
Immune complexes subjected to treatment with shrimp alkaline phos-
phatase were suspended in 15 
 
m
 
l phosphatase buffer (40 mM Hepes, pH
8.0, 10 mM magnesium chloride) and incubated for 30 min at 30
 
8
 
C with 1.5
U of shrimp alkaline phosphatase (United States Biochemical, Cleveland,
OH) in the presence or absence of phosphatase inhibitors (10 mM sodium
pyrophosphate, 5 mM EGTA, 5 mM EDTA). For immunoblot analysis,
the phosphatase reaction was terminated with the addition of 5 
 
m
 
l of 4
 
3
 
sample buffer, and the beads were boiled for 5 min.
 
To determine if phosphorylation alters the in vitro catalytic activity of
Spo14p, the phosphatase reactions were quenched with the addition of l
ml ice-cold TBS containing phosphatase inhibitors. The immune complex
was then split into two equal halves. One half was suspended in 20 
 
m
 
l 1
 
3
 
sample buffer and boiled for 5 min. The remaining half of the immuno-
complex was washed once in 1 ml ice-cold PLD assay buffer supple-
mented with phosphatase inhibitors and suspended in 50 
 
m
 
l of 2
 
3
 
 PLD as-
say buffer containing phosphatase inhibitors. The PLD reaction was
initiated as described above. 
 
In Vivo [
 
32
 
P]PO
 
4
2
 
2
 
 Labeling of HA-Spo14p
 
Sporulation cultures were washed twice with water and once in sphero-
plast labeling solution (200 mM MES, pH 6, 1 M sorbitol). Cells were then
suspended in a total volume of 10 ml spheroplast labeling solution con-
taining 20 mM DTT and 5 mCi [
 
32
 
P]PO
 
4
2
 
2
 
. After 30 min at 30
 
8
 
C, 1 mg of
zymolyase 100T was added, and the cells were incubated for a further 30
min at 308C. [32P]PO4
22-labeled spheroplasts were washed once in label-
ing solution and HA-Spo14p was immunoprecipitated directly from the
Nonidet P-40–soluble fraction as described above. Immune complexes
were boiled in sample buffer for immunoblot analysis. 
Immunoblot Analysis
Cell extracts or immunoprecipitates prepared as described above were
centrifuged at 16,000 g for 10 min before being subjected to SDS-PAGE
on 5% SDS–polyacrylamide gels. Proteins were electrophoretically trans-
ferred onto nitrocellulose membranes (pore size: 0.45 mm; Bio-Rad Labo-
ratories, Hercules, CA) for 22–24 h. Blots were blocked by incubation for
2 h at room temperature with 10% nonfat dry milk in TBS with 0.2%
Tween-20 (vol/vol). Blots were then washed three times for 10 min with
TBS-T (TBS with 0.1% Tween-20 [vol/vol]) and incubated with mAb
12CA5 diluted 1:3,000 in TBS-T with 1% fatty acid–free BSA (wt/vol) for
2 h. After three washes with TBS-T, blots were incubated for 2 h with
horseradish peroxidase–conjugated anti–mouse antiserum (Amersham
International, Buckinghamshire, England) diluted 1:5,000 in TBS-T with
1% fatty acid–free BSA (wt/vol). After three final washes in TBS-T, pro-
teins on immunoblots were visualized by enhanced chemiluminescence
detection on preflashed film. The resulting films were quantitated on an
imaging densitometer (model GS-670; Bio-Rad Laboratories).
Cytology
Yeast strains used for cytology were derived from the rapidly sporulating
strain SK1 (Kane and Roth, 1974; Hollingsworth et al., 1995) and were
grown and sporulated as previously described (Krisak et al., 1994). Living
cells were examined by fluorescence microscopy on the fluorescein chan-
nel. Double labeling experiments were performed by fixing cells with
3.7% formaldehyde for 10 min at room temperature. Immunofluores-
cence with antitubulin antibody (YOL1/34; Kilmartin et al., 1982; Accu-
Table I. Yeast Strains
Strain Genotype Source
KR52-3C HO ura3-1 leu2 arg4-8 thr1-4 trp1-1 ade2 spo14::URA3 Rose et al., 1995
HO ura3-1 leu2 arg4-8 thr1-4 trp1-1 ade2 spo14::URA3
Y501 KR52-3C, plus pME865 (SPO14 LEU2 CEN) This study
Y568 KR52-3C, plus pME940 (HA-SPO14 LEU2 CEN) This study
Y951 KR52-3C, plus pME1132 (HA-spo14DN LEU2 CEN) This study
Y795 KR52-3C, plus pME1043 (HA-spo14-K®H LEU2 CEN) This study
Y603 KR52-3C, plus pME962 (SPO14 LEU2 2m) This study
Y602 KR52-3C, plus pME957 (HA-SPO14 LEU2 2m) This study
Y1031 KR52-3C, plus pME1121 (HA-spo14-DN LEU2 2m) This study
NH144 MATa leu2-k HIS4 ho:: LYS2 ura3 lys2 arg4-Nsp Hollingsworth et al., 1995
MATa leu2::hisG his4-x ho::LYS2 ura3 lys2 ARG4
Y433 NH144 but homozygous spo14::URA3 This study
Y969 Y433, plus pME1096 (GFP-SPO14 LEU2 2m) This study
Y988 NH144, plus pME1124 (GFP-spo14-DN LEU2 2m) This study
Y989 Y433, plus pME1124 (GFP-spo14-DN LEU2 2m) This study
Y1019 NH144, plus pME1130 (GFP-spo14-K®H LEU2 2m) This study
Y1020 Y433, plus pME1130 (GFP-spo14-K®H LEU2 2m) This studyThe Journal of Cell Biology, Volume 140, 1998 84
rate Chemical and Scientific Corp., Westbury, NY), and 49-69diamin-
ophenylindole (DAPI) staining was performed as described (Pringle et al.,
1991).
Cells from strains NH144 and Y433 were sporulated and, at various
times, centrifuged, washed in H2O, and prepared for electron microscopy
as described (Friesen et al., 1994).
Results
PLD Activity Is Required but Not Sufficient for Meiosis
SPO14 belongs to a gene family with orthologs in verte-
brates, plants, and bacteria (Hammond et al., 1995; Rose
et al., 1995). Sequence alignments have defined five con-
served regions; regions II and IV contain triads of charged
amino acids that putatively mediate catalysis (Morris et al.,
1996), while the PX domain is postulated to mediate pro-
tein–protein interactions (Ponting, 1997; Fig. 1). Muta-
tional analysis has demonstrated that the putative catalytic
triads are essential for human PLD1 and Spo14p catalytic
activity (Sung et al., 1997). Furthermore, spo14 deletion
strains expressing a protein containing an amino acid
change in one of these triads, Spo14pK®H, are unable to
sporulate (Sung et al., 1997; Fig. 1), indicating that PLD
catalytic activity is essential for Spo14p function. 
In addition to the conserved domains, Spo14p contains a
large NH2-terminal extension that does not display simi-
larity to other PLD family members (Fig. 1). To determine
the function of this domain, a protein lacking 150 amino
acids in the NH2-terminal portion of the protein, Spo14pDN,
was constructed and analyzed. spo14 deletion strains ex-
pressing spo14-DN are unable to sporulate, indicating that
this region is also essential for Spo14p function. 
To examine protein and catalytic activity, sequences en-
coding three epitopes from the influenza virus hemaggluti-
nin protein (HA) were introduced into SPO14, spo14-DN
and  spo14-K®H. The resulting products, HA-Spo14p,
HA-Spo14pDN, and HA-Spo14pK®H, respectively, allowed
for the specific detection of these proteins with the mono-
clonal antibody 12CA5. HA-SPO14 CEN (expressed from
a low copy centromeric plasmid) enabled a yeast strain de-
leted for the SPO14 gene (Y568) to sporulate as well as wild-
type SPO14 CEN (Y501) (59 vs. 58%, respectively), while
neither HA-spo14-DN CEN nor HA-spo14K®H CEN res-
cued the sporulation defect of the spo14 mutant (Y951,
Y795; ,0.01% sporulation; Fig. 2 B).
Immunoprecipitations were performed from cells har-
boring the different Spo14 proteins induced to undergo
meiosis. The amount of HA-Spo14p immunoprecipitated
represents z95% of the total protein expressed. The im-
munoprecipitates were examined by immunoblot analysis
and assayed for PLD activity. As shown in Fig. 2 A, a pro-
tein of z210 kD is specifically detected in immunoprecipi-
tates from cells expressing HA-SPO14 or HA-spo14-K®H
but not from cells expressing SPO14 without the HA se-
quences. A protein of z190 kD is immunoprecipitated
from cells expressing HA-spo14-DN. The predicted molecu-
lar masses of the proteins are 195 kD (Spo14p, Spo14pK®H;
Rose et al., 1995) and 180 kD (Spo14pDN). While all three
Figure 1. Alterations in the Spo14 protein. Boxed regions denote
conserved domains in PLD gene family members (PX, Ponting,
1997; I, II, III, and IV, Morris et al., 1996). The two putative cata-
lytic triads and the single amino acid change in Spo14pK®H are
designated. DN refers to the NH2-terminal deletion in Spo14pDN.
Figure 2. Protein and PLD activity of Spo14 variants. (A) Immu-
noblot blot analysis of immunoprecipitates from cells harboring
SPO14 CEN (lane Spo14p; Y501), HA-SPO14 CEN (lane HA-
Spo14p; Y568), HA-spo14-DN CEN (lane HA-Spo14pDN; Y951),
HA-spo14-K®H CEN (lane HA-Spo14pK®H; Y795), HA-SPO14
2m (lane HA-Spo14p 2m; Y602), and HA-spo14-DN 2m (lane HA-
Spo14pDN 2m; Y1031). The numbers on the left of the immuno-
blot indicate the positions of molecular mass standards (kD). (B)
Sporulation (white bars) and total PLD activity (hatched bars)
and relative PLD specific activity (black bars) of the correspond-
ing proteins. PLD assays were performed with vesicles containing
100 mM BODIPY-PC and 5 mM PIP2.Rudge et al. Phospholipase D Mediates Membrane Formation 85
proteins are synthesized, the amount of protein and PLD
activity immunoprecipitated from the different strains was
not equal. There was approximately fivefold less protein
and 15-fold less PLD activity immunoprecipitated from
cells harboring HA-Spo14pDN compared with HA-Spo14p
(Fig. 2). When protein amounts are taken into account, the
specific PLD activity of HA-Spo14pDN is decreased ap-
proximately threefold compared with the wild-type pro-
tein. In contrast, the relative specific PLD activity of HA-
Spo14pK®H is 30-fold less than the wild-type protein (Fig.
2; Sung et al., 1997).
To determine if HA-spo14-DN is unable to rescue the
sporulation defect of spo14 null mutants because there
is less protein and PLD activity, HA-spo14-DN was ex-
pressed from a 2m plasmid, which is present at high copy
number within yeast cells (for review see Broach and
Volkert, 1991). Cells expressing HA-spo14-DN from a 2m
plasmid were unable to sporulate (Y1031; ,0.01% sporu-
lation), while cells expressing HA-SPO14 from a 2m plas-
mid sporulated as efficiently as when these sequences
were expressed on a centromere plasmid (56 vs. 59% spor-
ulation for strain Y602 and Y568, respectively; Fig. 2 B).
The catalytically inactive protein expressed from a 2m
plasmid also failed to complement the sporulation defect
of spo14 null mutants (data not shown). Immunoblot anal-
ysis and activity assays revealed that approximately nine
times more full-length protein and ten times more PLD
activity were immunoprecipitated from strains harboring
HA-spo14-DN 2m compared with strains harboring HA-
spo14-DN CEN (Fig. 2). A faster-migrating species was
also observed in immunoprecipitates from cells expressing
this protein from a 2m plasmid and is probably a degrada-
tive product of the full-length HA-Spo14pDN. Thus, the to-
tal amount of PLD activity is similar to the activity immu-
noprecipitated from cells expressing HA-SPO14 from
either a centromere or 2m plasmid. These results indicate
that the inability of spo14-DN to rescue the sporulation de-
fect of spo14 mutants is not caused by decreased PLD ac-
tivity.
Spo14p catalytic activity in vitro is dependent on the
lipid cofactor, phosphatidylinositol 4,5-bisphosphate (PIP2;
Rose et al., 1995). In this respect, Spo14p is similar to the
mammalian orthologs (Hammond et al., 1995; Colley et al.,
1997). No PLD activity was detected in the absence of
PIP2, indicating that like Spo14p, Spo14pDN is PIP2 depen-
dent (data not shown). Therefore, the inability of cells ex-
pressing HA-spo14-DN to sporulate is unlikely to be a con-
sequence of a change in the protein’s ability to respond to
its putative in vivo activator, PIP2.
Cell fractionation experiments were performed to deter-
mine the subcellular location of Spo14p in meiosis. HA-
Spo14p is found almost exclusively in the particulate frac-
tion (96%; Fig. 3), suggesting that Spo14p is associated
with membranes or exists in a large protein complex. HA-
Spo14pK®H also partitioned almost exclusively to the par-
ticulate fraction (92%; Fig. 3). In contrast, Spo14pDN is
found in nearly equivalent amounts in the cytosol (42%)
and the particulate fractions (58%; Fig. 3), raising the pos-
sibility that the failure of this protein to rescue a spo14 null
allele is due to mislocalization.
Spo14p Relocalizes during Meiosis
A GFP–Spo14 fusion was constructed, and its localization
was examined in living yeast cells. GFP–Spo14p is fully
functional; this fusion protein expressed from either a cen-
tromere or a 2m plasmid enables a spo14 null mutant to
sporulate as efficiently as wild type. Although GFP–Spo14p
expressed from a centromere plasmid rescued the sporula-
tion defect of spo14 null mutants, we were unable to detect
a fluorescent signal; however, a specific signal was de-
tected when this fusion was expressed from a 2m plasmid.
The top panel of Fig. 4 shows representative cells express-
ing GFP–SPO14 before induction of meiosis (0 hr) and
throughout meiosis (6–10 hr). In vegetative cells and early
in meiosis, GFP–Spo14p appears to be dispersed in the cy-
toplasm (Fig. 4, 0 hr). As meiosis progresses, GFP–Spo14p
converges into discrete foci (Fig. 4, 6 hr), expands into
ringlike structures (Fig. 4, 8 hr), and eventually enlarges to
outline the mature spore (Fig. 4, 10 hr).
Double labeling experiments with the DNA-specific dye
DAPI indicate that Spo14p begins to converge into spe-
cific foci at the meiosis I division (Fig. 4, middle). At meio-
sis II, these foci expand into circles that encompass the
four-lobed nucleus, which appear as elongated rings (Fig.
4, bottom). The spindle pole bodies are the sites of mem-
brane formation (Byers, 1981); therefore, we labeled yeast
cells harboring GFP–Spo14p with a monoclonal antibody
directed against tubulin. The discrete foci of GFP–Spo14p
after the meiosis I division colocalize with the ends of the
spindle, presumably at the spindle pole bodies (Fig. 4, middle).
Localized PLD Activity Is Required for
Membrane Formation
GFP derivatives of Spo14pDN and Spo14pK®H were con-
structed and examined in wild-type and spo14 deletion
Figure 3. Biochemical fractionation of Spo14 proteins. Immuno-
blot of particulate (P) and cytosolic (C) fractions prepared from
yeast cells harboring HA-SPO14 CEN (Y568), HA-spo14-DN
CEN (Y951), and HA-spo14-K®H CEN (Y795). The numbers
on the left of the immunoblot indicate the positions of molecular
mass standards (kD).The Journal of Cell Biology, Volume 140, 1998 86
mutants. In contrast to the wild-type protein, GFP–
Spo14pDN remains dispersed in the cytoplasm throughout
meiosis when expressed in either wild-type or mutant cells
(Fig. 5, top). Thus, consistent with the biochemical frac-
tionation, the failure of this protein to complement a
spo14 deletion strain is most likely due to its inability to
relocalize during meiosis.
Examination of GFP–Spo14pK®H in wild-type and spo14
deletion cells revealed that this protein relocalized to the
spindle pole bodies after the meiosis I division in the ma-
jority of the cells examined (Fig. 5, middle). However,
while membranes were observed in wild-type cells ex-
pressing GFP–Spo14pK®H (Fig. 5, bottom), no membrane
structures were observed in spo14 deletion cells expressing
GFP–Spo14pK®H.
To confirm that in the absence of PLD activity no spore
membrane is formed, we examined thin sections of yeast
cells induced to sporulate by electron microscopy. In wild-
type cells, the spore membrane and spore wall layers were
observed readily as discrete compartmentalized entities
within the body of the mother cell (Fig. 6 A). In contrast,
in greater than 100 cells examined, no compartmentaliza-
tion was observed in spo14 null mutants, indicating that no
membrane nor spore wall is formed (Fig. 6 B). Taken to-
gether, these results indicate that relocalization of PLD ac-
tivity is essential for the formation of the spore membrane
that encompasses the haploid meiotic nuclei.
Phosphorylation of Spo14p Correlates
with Relocalization
Immunoblot analysis of whole cell extracts derived from
cells harboring HA-Spo14p revealed that Spo14p changes
electrophoretic mobility during meiosis (Fig. 7 A). The
Figure 4. Relocalization of
GFP–Spo14p during meio-
sis. (Top) Micrographs of liv-
ing yeast cells harboring
GFP–SPO14  2m  (Y969) at
the indicated times after in-
duction of meiosis. (Middle)
A fixed cell after the meiosis I division showing GFP–Spo14p
(Spo14p), antitubulin antibody (Tubulin) and DAPI (DNA) labeling. A
schematic representation of the cell is on the right. The circles repre-
sent Spo14p, lines represent the spindles, and the ovals represent
DNA. The dashed line is the nuclear envelope. (Bottom) A cell ex-
pressing GFP–Spo14p (Spo14p) after the meiosis II division stained
with DAPI (DNA).
Figure 5. Visualization of GFP–Spo14pDN
and GFP–Spo14pK®H during meiosis.
(Top) Live cells expressing GFP–Spo14pDN
(live; Y988) and a fixed cell expressing
GFP–Spo14pDN ( Spo14pDN), labeled
with antitubulin antibodies (Tubulin)
and DAPI (DNA). (Middle) spo14 mu-
tant cells expressing GFP–Spo14pK®H
(Y1020)  showing GFP (Spo14pK®H ), an-
titubulin antibody (Tubulin) and DAPI
(DNA) labeling. (Bottom) Wild-type cells
expressing GFP–Spo14pK®H (Spo14pK®H;
Y1019) late in meiosis.Rudge et al. Phospholipase D Mediates Membrane Formation 87
shift in apparent molecular mass of HA-Spo14p during
meiosis suggests that the protein is posttranslationally
modified. Phosphorylation is a common protein modifica-
tion and has been shown to affect enzymatic activity (Liu
and Simon, 1996) and protein localization (Keranen et al.,
1995). To determine if Spo14p is a phosphoprotein, immu-
noprecipitates of HA-Spo14p were performed from mei-
otic cells that were labeled in vivo with [32P]orthophos-
phate. Label was specifically incorporated into HA-
Spo14p (Fig. 7 B), indicating that Spo14p is phosphory-
lated during meiosis.
To determine whether phosphorylation is altered in the
mutant proteins, HA-Spo14p, HA-Spo14pDN, and HA-
Spo14pK®H were immunoprecipitated from yeast cells in-
duced in meiosis. The immunoprecipitates were incubated
with alkaline phosphatase and analyzed by immunoblot-
ting. Treatment of the immunoprecipitated products with
alkaline phosphatase converted HA-Spo14p and HA-
Spo14pK®H to faster migrating species; the presence of
phosphatase inhibitors prevented the shift in mobility (Fig.
7 C). The dephosphorylated species migrated faster than
the proteins derived from mitotic cells (data not shown);
these results suggest that more than one residue on Spo14p
is phosphorylated, and at least one of these sites is specifi-
cally modified during meiosis. In contrast to HA-Spo14p
and HA-Spo14pK®H, treatment of immunoprecipitated
HA-Spo14pDN with alkaline phosphatase did not result in
a change in electrophoretic mobility (Fig. 7 C). To confirm
that phosphorylation is altered in Spo14pDN, we labeled
HA-Spo14p and HA-Spo14pDN in vivo with [32P]ortho-
phosphate. Consistent with the analysis of phosphatase
sensitivity, approximately seven-fold less label was incor-
porated into HA-Spo14pDN, compared with HA-Spo14p
(Fig. 7 D). In addition, analysis of the phosphorylation
state of LexA–Spo14 fusion proteins in meiosis indicates
that the majority of phosphorylated residues map to the
NH2-terminal region defined by the Spo14pDN deletion
(data not shown).
To determine if phosphorylation alters the in vitro cata-
lytic activity of Spo14p, we performed PLD assays on the
immunoprecipitated protein before and after treatment
with alkaline phosphatase. As shown in Fig. 7 E, in vitro
PLD activity was unaffected by the phosphorylation state
of the protein. Taken together, these results suggest that
phosphorylated residues in the 150 amino acids defined by
the deletion are important for relocalization.
Figure 6. Electron micros-
copy of sporulated SPO14/
SPO14 (NH144) and spo14/
spo14 (Y433) cells. (A) A
typical wild-type cell late in
sporulation (12 h) showing
three spore-like compart-
ments. (B) A typical spo14
cell at the same time showing
three nuclei but no compart-
mentalization.  SC, spore
compartment; N ,  nucleus.
Bars, 500 nm.
Discussion 
In this paper, we have shown that the localization of
Spo14p is specifically altered during meiosis and that both
proper redistribution and catalytic activity are required for
the formation of the internal spore membrane. The meio-
sis-specific relocalization of Spo14p appears to be medi-
ated by the nonconserved NH2-terminal portion of the
protein and correlates with phosphorylation. However,
while this region of the protein is necessary for relocaliza-
tion, we have not demonstrated sufficiency. These results
emphasize the importance of subcellular localization and
posttranslational modification of PLD in regulating cellu-
lar differentiation.
Spo14p is present and active in mitotically dividing cells
as measured by an in vitro assay; however, no effect on
vegetative growth has been detected in spo14 deletion
strains (Rose et al., 1995). The diffuse staining observed in
mitotically dividing cells suggests that while active, the pro-
tein does not have access to its lipid cofactor, PIP2, or sub-
strate, PC, and consequently does not generate PA or
other biologically active lipids. Consistent with this idea,
Spo14p isolated from mitotically dividing cells and early in
meiosis is not solubilized with nonionic detergent at con-
centrations that are known to release membrane-bound
proteins, suggesting that the particulate nature of Spo14p
is due to association with a large protein complex such as
the cytoskeleton. However, at the time of the meiotic divi-
sions, Spo14p is readily solubilized by such treatment,
indicating that it becomes associated with cellular mem-
branes (Rudge, S.A., and J. Engebrecht, unpublished data).
Thus, it seems likely that meiotic development triggers ac-
tivation of Spo14p by relocalizing it to membranes.
Recent work has suggested a role for PLD activity in
yeast Golgi function during mitotic growth (Patton-Vogt
et al., 1997). Such a role was uncovered in a multigenic
mutant and raises the possibility that Spo14p can be local-
ized to Golgi membranes during mitotic growth. In fact, it
is possible that Spo14p initially moves to the Golgi before
movement to the spindle pole bodies during meiosis.
The relocalization of proteins to their lipid substrate is a
common theme for the activation of proteins involved in
signal transduction. For example, thrombin provokes the
translocation of p110 phosphatidylinositol-3 kinase (Zhang
et al., 1992) and phosphatidylinositol 4-phosphate 5-kinase
(Hinchliffe et al., 1996) to the membrane cytoskeleton ofThe Journal of Cell Biology, Volume 140, 1998 88
platelets. Moreover, phospholipase Cg translocates from
the cytosol to the membrane fraction of HER14 cells in re-
sponse to epidermal growth factor and platelet-derived
growth factor, and this relocalization appears to be pro-
moted by tyrosine phosphorylation (Kim et al., 1990).
Protein kinase C bII also undergoes translocation from
a detergent-insoluble to a detergent-soluble cell fraction
that contains its lipid cofactors, phosphatidylserine and di-
acylglycerol (Keranen et al., 1995). Recently, at least two
classes of PKC-binding proteins have been identified that
are not substrates for the kinase (receptors for activated
C-kinase and proteins that interact with C-kinase; for re-
view see Faux and Scott, 1996). These proteins are be-
lieved to participate in PKC targeting. Therefore, PKC trans-
location involves not only protein–lipid interactions but
also protein–protein interactions. During meiosis, Spo14p
relocalization to its membrane target might also involve
binding to both its phospholipid substrate and cofactor,
and to a putative Spo14p receptor protein.
What kinase(s) are responsible for phosphorylating
Spo14p? Phosphatase sensitivity and in vivo labeling ex-
periments suggest that there is more than one residue that
is modified by phosphorylation. Whether a single kinase
or multiple kinases are responsible for these phosphoryla-
tion events remains to be determined. Preliminary data
suggest that phosphorylation occurs predominantly on
serine and/or threonine residues (Rudge, S.A., and J. En-
gebrecht, unpublished data). In the region defined by
Spo14pDN, two of the serine and threonine residues con-
form to the consensus sequence for PKC, a known activa-
tor of mammalian PLD (Conricode et al., 1992; Lopez et al.,
1995; Singer et al., 1996; Hammond et al., 1997). As stated
above, mammalian PKC translocates from a detergent-
insoluble cell fraction to a detergent-soluble fraction upon
activation (Keranen et al., 1995). Therefore, yeast Pkc1p
might phosphorylate Spo14p and translocate with it upon
activation. Expression of an activated allele of PCK1
(PCK1-R398P; Nonaka et al., 1995) in mitotically dividing
cells did not result in phosphorylation or relocalization of
Spo14p, indicating that Pkc1p is not the kinase responsible
for these events (Rudge, S.A., and J. Engebrecht, unpub-
lished). Moreover, expression of PCK1-R398P in vegeta-
tive cells did not alter Spo14p catalytic activity. However,
we cannot rule out the possibility that Pkc1p itself is spe-
cifically activated during meiosis and consequently pro-
motes the phosphorylation and relocalization of Spo14p.
The localization pattern of Spo14p is similar to that of
Spr3p, Cdc3p, and Cdc10p, yeast septins that play partially
redundant roles during the process of spore formation
(Fares et al., 1996). However, while spo14 mutants are de-
fective in meiosis and do not synthesize the spore mem-
brane, septin mutants are only partially defective in spore
formation. Furthermore, Spo14p is found uniformly around
the growing membrane, while the septins appear to define
the leading edge of the spore membrane.
Examination of GFP–Spo14 fusions was only possible
when these sequences were expressed on 2m plasmids,
which exist in multiple copies per cell (Broach and Volk-
ert, 1991). Expression of the wild-type protein on a 2m
plasmid is not deleterious, indicating that there is no gross
effect of overexpression. While we can not eliminate the
possibility that overexpression alters the localization pat-
tern, the relocalization of GFP–Spo14p is consistent with
biochemical fractionation studies performed on cells con-
taining endogenous levels of protein.
The results presented here suggest that PLD partici-
pates in regulated membrane formation during meiosis.
Figure 7. Phosphorylation of Spo14 proteins during meiosis. (A)
Immunoblot of Y568 whole cell protein extracts containing HA-
Spo14p prepared from mitotically dividing cells (lane mt) and mid-
way through meiosis (lane me). (B) Autoradiograph of immuno-
precipitates derived from meiotic yeast cells harboring either
Spo14p 2m (Y603) or HA-Spo14p 2m (Y602) labeled with 32P
([32P]) and the corresponding immunoblot (Anti-HA). (C) Im-
munoblot of immunoprecipitated HA-Spo14p (Y568), HA-
Spo14pDN (Y951), and HA-Spo14pK®H (Y795) from meiotic
yeast cells treated with either shrimp alkaline phosphatase buffer
(P`tase buffer) or shrimp alkaline phosphatase (P`tase) with or
without phosphatase inhibitors (P`tase Inhibitors). (D) Autorad-
iograph of immunoprecipitates derived from 32P-labeled meiotic
yeast cells harboring either HA-Spo14p 2m (Y602) or HA-
Spo14pDN 2m (Y1031) ([32P]) and the corresponding immunoblot
(Anti-HA). (E) PLD activity and immunoblot of immunoprecipi-
tated meiotic HA-Spo14p (Y568) treated with shrimp alkaline
phosphatase in the presence and absence of phosphatase inhibi-
tors. PLD assays were performed with vesicles containing 10 mM
BODIPY-PC and 5 mM PIP2. The numbers on the left of the im-
munoblot indicate the positions of molecular mass standards (kD).Rudge et al. Phospholipase D Mediates Membrane Formation 89
This could occur in several ways. First, Spo14p may gener-
ate a lipid required for the formation of the internal spore
membrane. Generation of PA or DAG could alter the char-
acteristics of membranes to promote membrane curvature,
similar to what is postulated to underlie the generation of
Golgi vesicles (Ktistakis et al., 1996; Kearns et al., 1997).
This could be important in the process of encapsulation of
the nuclei and perhaps also for the generation of the vesi-
cles that fuse to form the spore membrane. Alternatively,
Spo14p could synthesize another lipid important for mem-
brane formation. PLD has been proposed to synthesize
bisphosphatidic acid, which is formed through transphos-
phatidylation when DAG is used as a nucleophile donor
instead of water (van Blitterswijk and Hilkmann, 1993). A
derivative of this lipid, semilysobisphosphatidic acid, has
been shown to be a component of Golgi membranes and is
also predicted to induce membrane curvature (Cluett and
Machamer, 1996). Cluett and Machamer (1996) hypothesize
that this lipid may be important for stabilizing membranes
during vesicle budding and fusion events, both of which
are likely to be essential for spore membrane formation.
Second, localized PLD activity may generate PA or DAG
as a signal to activate downstream effectors important for
membrane formation. This may lead to cytoskeletal reor-
ganization, similar to what is observed in the formation of
actin stress fibers (Cross et al., 1996). Cytoskeletal compo-
nents are likely to mediate alignment of vesicles for direct-
ing membrane formation around the nuclear envelope.
Third, PLD may generate lipids for both activating down-
stream effectors and membrane formation. Future studies
should define which of the putative lipid products of PLD
mediate the formation of this internal membrane and co-
ordinate its synthesis to the nuclear events of meiosis.
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